Aran D, Looney AP, Liu L, Wu E, Fong V et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20(2):163–172

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arpinati L, Scherz-Shouval R (2023) From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer 9(5):421–443

Article  PubMed  CAS  Google Scholar 

Asciak R, George V, Rahman NM (2021) Update on biology and management of mesothelioma. Eur Respir Rev 30(159):200226

Article  PubMed  PubMed Central  Google Scholar 

Bertuccio FR, Agustoni F, Galli G, Bortolotto C, Saddi J et al (2023) Pleural mesothelioma: treatable traits of a heterogeneous disease. Cancers (Basel) 15(24):5731

Article  PubMed  CAS  Google Scholar 

Burt BM, Rodig SJ, Tilleman TR, Elbardissi AW, Bueno R et al (2011) Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer 117(22):5234–5244

Article  PubMed  CAS  Google Scholar 

Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F et al (2019) Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin 69(5):402–429

PubMed  PubMed Central  Google Scholar 

Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G et al (2023) Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet 55(1):44–53

Article  PubMed  PubMed Central  Google Scholar 

Doig CL, Zielinska AE, Fletcher RS, Oakey LA, Elhassan YS et al (2020) Induction of the nicotinamide riboside kinase NAD(+) salvage pathway in a model of sarcoplasmic reticulum dysfunction. Skelet Muscle 10(1):5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53(12):1712–1721

Article  PubMed  CAS  Google Scholar 

Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383):eaag1166

Article  PubMed  PubMed Central  Google Scholar 

Guo Z, Carbone M, Zhang X, Su D, Sun W et al (2017) Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol 12(4):714–723

Article  PubMed  Google Scholar 

Hanks SC, Forer L, Schonherr S, LeFaive J, Martins T et al (2022) Extent to which array genotyping and imputation with large reference panels approximate deep whole-genome sequencing. Am J Hum Genet 109(9):1653–1666

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsu WH, LaBella KA, Lin Y, Xu P, Lee R et al (2023) Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov 13(12):2652–2673

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang J, Sun J, Wang K, Zheng L, Fan Y et al (2024) Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study. BMC Cancer 24(1):774

Article  PubMed  PubMed Central  Google Scholar 

Hung YP, Dong F, Dubuc AM, Dal Cin P, Bueno R et al (2020) Molecular characterization of localized pleural mesothelioma. Mod Pathol 33(2):271–280

Article  PubMed  CAS  Google Scholar 

Ireland DJ, Kissick HT, Beilharz MW (2012) The role of regulatory T cells in mesothelioma. Cancer Microenviron 5(2):165–172

Article  PubMed  PubMed Central  CAS  Google Scholar 

Janes SM, Alrifai D, Fennell DA (2021) Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med 385(13):1207–1218

Article  PubMed  CAS  Google Scholar 

Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li P, Zhang H, Chen T, Zhou Y, Yang J et al (2024) Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer. Matrix Biol 132:59–71

Article  PubMed  CAS  Google Scholar 

Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22(6):bbab260

Article  PubMed  PubMed Central  Google Scholar 

Mao X, Xu J, Wang W, Liang C, Hua J et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20(1):131

Article  PubMed  PubMed Central  CAS  Google Scholar 

Marbet P, Klusonova P, Birk J, Kratschmar DV, Odermatt A (2018) Absence of hexose-6-phosphate dehydrogenase results in reduced overall glucose consumption but does not prevent 11beta-hydroxysteroid dehydrogenase-1-dependent glucocorticoid activation. FEBS J 285(21):3993–4004

Article  PubMed  CAS  Google Scholar 

Meloni F, Morosini M, Solari N, Passadore I, Nascimbene C et al (2006) Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 67(1–2):1–12

Article  PubMed  CAS  Google Scholar 

Obacz J, Yung H, Shamseddin M, Linnane E, Liu X et al (2021) Biological basis for novel mesothelioma therapies. Br J Cancer 125(8):1039–1055

Article  PubMed  PubMed Central  Google Scholar 

Orru V, Steri M, Sidore C, Marongiu M, Serra V et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036–1045

Article  PubMed  PubMed Central  CAS  Google Scholar 

Roden DM, McLeod HL, Relling MV, Williams MS, Mensah GA et al (2019) Pharmacogenomics Lancet 394(10197):521–532

Article  PubMed  CAS  Google Scholar 

Sadee W, Wang D, Hartmann K, Toland AE (2023) Pharmacogenomics: Driving Personalized Medicine. Pharmacol Rev 75(4):789–814

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saleh A, Al-Abcha A, Pereira N (2023) Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol 38(3):207–214

Article  PubMed  Google Scholar 

Tao L, Cui Y, Sun J, Cao Y, Dai Z et al (2023) Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma. Front Cell Dev Biol 11:1171047

Article  PubMed  PubMed Central  Google Scholar 

Therneau TM, Grambsch PM (2000) Modeling survival data: extending the cox model. Springer

Book  Google Scholar 

Tsao AS, Pass HI, Rimner A, Mansfield AS (2022) New era for malignant pleural mesothelioma: updates on therapeutic options. J Clin Oncol 40(6):681–692

Article  PubMed